BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Dextromethorphan

the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.

296+ PubMed studies analyzed · 52 RCTs · Evidence Score: 49.9

Research Domains

Dextromethorphan has been studied across 14 research domains including 💊 Pain, 🌤️ Mood & Depression, 😴 Sleep, 🫁 Liver & Detox, 🧠 Neuroprotection. The primary research focus is 💊 Pain with 17% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dextromethorphan, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dextrorphan
9 shared targets
Levorphanol
11 shared targets
Ibotenic
8 shared targets
D-Aspartic
7 shared targets
Dizocilpine
7 shared targets
Glycine
8 shared targets
Aspartic
7 shared targets
cycloserine
7 shared targets
protriptyline
10 shared targets
Phentolamine
12 shared targets
Loading evidence profile...

This evidence profile for Dextromethorphan is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.